Rubella was declared eliminated in the U.S.
In 2004, Rubella, also known as German measles, was declared eliminated in the U.S. Before the rubella vaccination…
The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Michael Smith Genome Science Centre sequenced the SARS genome
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
Biotechnology | Disease | HIV | Vaccine
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…
Public health officials were concerned about re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
FDA | Infectious Disease | Polio | Vaccine
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
President Bush announced a major smallpox vaccination program
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
Diagnostics | Infectious Disease | Polio | Vaccine | WHO
The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Rotary International launched a second fundraising campaign to eradicate polio
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
Institute of Medicine called for creation of a national vaccine authority
On Nov. 5, 2001, following the events of September 11, the Institute of Medicine again called for creation…
The CDC learned of a domestic terrorism attack via anthrax sent through the mail
On Sept. 11, 2001, the U.S. Centers for Disease Control and Prevention (CDC) learned of a domestic terrorism…
A combined hepatitis A inactivated and hepatitis B (recombinant) vaccine was licensed
On May 11, 2001, the Food and Drug Administration (FDA) licensed a combined hepatitis A and B vaccine…
The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines
In 2001, The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines tailored…
The CDC responded to the World Trade Center and bioterrorism anthrax attacks
In 2001, the U.S. Centers for Disease Control and Prevention (CDC) responded to the World Trade Center and…
Peter St. George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice
On Dec. 21, 2000, Dr. Peter St George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice. The…
Biotechnology | Infectious Disease | Polio | Vaccine | WHO
The Western Pacific Region of the world was certified as polio-free
On Oct. 29, 2000, the Regional Commission for the Certification of Poliomyelitis Eradication certified that the Western Pacific…
NIAID created global network to advance development of HIV vaccines
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….
A 7-valent pneumococcal conjugate vaccine was licensed
On Feb. 17, 2000, the Food and Drug Administration (FDA) announced it it had licensed a 13-valent pneumococcal…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
The use of Oral polio vaccine (OPV) was discontinued in the U.S.
In 2000, the use of Oral polio vaccine (OPV) was discontinued in the U.S. to eliminate the risk…
Measles was declared no longer endemic in the U.S.
In 2000, measles was declared no longer endemic in the U.S. following eradication campaigns that began in 1967….
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….